Aigli G. Vakrakou

74, Vasilissis Sofias Avenue
Athens, ESYE31 11528, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Rituximab treatment in AChR-positive generalized myasthenia gravis within two years of diagnosis.

Rituximab treatment in AChR-positive generalized myasthenia gravis within two years of diagnosis.

Journal: Clinical neurology and neurosurgery

Published: May 26, 2026

Circulating miRNA-30a is associated with favorable therapeutic outcome in patients with gastric cancer treated with neoadjuvant chemotherapy.

Circulating miRNA-30a is associated with favorable therapeutic outcome in patients with gastric cancer treated with neoadjuvant chemotherapy.

Journal: Oncology letters

Published: March 24, 2026

Complement C4d Informs the Differential Diagnosis of Inflammatory Demyelinating CNS Diseases.

Complement C4d Informs the Differential Diagnosis of Inflammatory Demyelinating CNS Diseases.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: December 23, 2025

Advanced quantitative MRI reveals a unique pattern of metabolic alterations and iron-pathology linked to glial activation in Baló's concentric sclerosis.

Advanced quantitative MRI reveals a unique pattern of metabolic alterations and iron-pathology linked to glial activation in Baló's concentric sclerosis.

Journal: Journal of neuroimmunology

Published: September 02, 2025

Cell-free DNA integrity and complement C4d as novel liquid biopsy biomarkers for paraneoplastic and non-paraneoplastic autoimmune encephalitis.

Cell-free DNA integrity and complement C4d as novel liquid biopsy biomarkers for paraneoplastic and non-paraneoplastic autoimmune encephalitis.

Journal: Frontiers in immunology

Published: June 03, 2025

Exploratory Analysis of Cerebrospinal Fluid IL-6 and IL-17A Levels in Subcortical Small-Vessel Disease Compared to Alzheimer's Disease: A Pilot Study.

Exploratory Analysis of Cerebrospinal Fluid IL-6 and IL-17A Levels in Subcortical Small-Vessel Disease Compared to Alzheimer's Disease: A Pilot Study.

Journal: Diagnostics (Basel, Switzerland)

Published: December 17, 2024

Phenotypic patterns and response to immunotherapy in a group of Very Late Onset Myasthenia Gravis: a single center study.

Phenotypic patterns and response to immunotherapy in a group of Very Late Onset Myasthenia Gravis: a single center study.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: September 30, 2024

Neurodegeneration correlates of iron-related lesions and leptomeningeal inflammation in multiple sclerosis clinical subtypes.

Neurodegeneration correlates of iron-related lesions and leptomeningeal inflammation in multiple sclerosis clinical subtypes.

Journal: Neuroradiology

Published: September 26, 2024

Central nervous system B-cell lymphoma in a patient diagnosed with chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids: A case report.

Central nervous system B-cell lymphoma in a patient diagnosed with chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids: A case report.

Journal: SAGE open medical case reports

Published: September 11, 2024

Osteopontin Regulates Treg Cell Stability and Function with Implications for Anti-Tumor Immunity and Autoimmunity.

Osteopontin Regulates Treg Cell Stability and Function with Implications for Anti-Tumor Immunity and Autoimmunity.

Journal: Cancers

Published: July 29, 2024

Efficiency of cell-based assays in detecting AChR antibodies in myasthenia gravis sera with low antibody concentrations as determined by radioimmunoprecipitation assay.

Efficiency of cell-based assays in detecting AChR antibodies in myasthenia gravis sera with low antibody concentrations as determined by radioimmunoprecipitation assay.

Journal: Frontiers in immunology

Published: July 04, 2024

Neuronal nicotinic acetylcholine receptor antibodies in autoimmune central nervous system disorders.

Neuronal nicotinic acetylcholine receptor antibodies in autoimmune central nervous system disorders.

Journal: Frontiers in immunology

Published: February 20, 2024

Showing 1-12 of 45

Last Updated: 09/26/2026